Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 56 entries
View as:

A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Phase: N/A Priority: Normal
NCT ID: NCT01936688 Org: User:
Start: 09/30/13 End: 08/31/18 Due: 08/31/19

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03245385 Org: User:
Start: 07/24/17 End: 02/05/18 Due: 02/05/19

A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT01478555 Org: User:
Start: 01/31/18 End: 01/31/19 Due: 01/31/20

A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)

Phase: N/A Priority: Normal
NCT ID: NCT01722331 Org: User:
Start: 12/06/12 End: 11/10/21 Due: 11/10/22

A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne

Phase: N/A Priority: Normal
NCT ID: NCT06336629 Org: User:
Start: 11/15/23 End: 07/10/24 Due: 07/10/25

Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01576952 Org: User:
Start: 07/31/12 End: 01/31/13 Due: 01/31/14

Effect of Cequa™ in Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT04357795 Org: User:
Start: 06/29/20 End: 06/24/22 Due: 06/24/23

Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

Phase: N/A Priority: Normal
NCT ID: NCT01408082 Org: User:
Start: 10/31/11 End: 06/30/13 Due: 06/30/14

Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04991116 Org: User:
Start: 06/30/22 End: 04/30/29 Due: 04/30/30

Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01406717 Org: User:
Start: 03/01/13 End: 11/04/15 Due: 11/04/16

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02534896 Org: User:
Start: 11/30/15 End: 06/30/18 Due: 06/30/19

Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Phase: N/A Priority: Normal
NCT ID: NCT02688556 Org: User:
Start: 02/29/16 End: 12/31/16 Due: 12/31/17

Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03897088 Org: User:
Start: 03/29/19 End: 02/17/22 Due: 02/17/23

A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients

Phase: N/A Priority: Normal
NCT ID: NCT06415279 Org: User:
Start: 02/29/24 End: 02/18/25 Due: 02/18/26

ABSORICA in Patients With Severe Recalcitrant Nodular Acne

Phase: N/A Priority: Normal
NCT ID: NCT02457520 Org: User:
Start: 01/21/15 End: 04/30/18 Due: 04/30/19

Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03192137 Org: User:
Start: 01/30/18 End: 04/17/19 Due: 04/17/20

Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01808547 Org: User:
Start: 05/31/13 End: 11/30/13 Due: 11/30/14

Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

Phase: N/A Priority: Normal
NCT ID: NCT01288625 Org: User:
Start: - End: - Due: -

An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Phase: N/A Priority: Normal
NCT ID: NCT02845674 Org: User:
Start: 07/29/16 End: 08/15/17 Due: 08/15/18

A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients

Phase: N/A Priority: Normal
NCT ID: NCT06415292 Org: User:
Start: 11/27/23 End: 12/16/23 Due: 12/16/24

Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Phase: N/A Priority: Normal
NCT ID: NCT02254265 Org: User:
Start: 09/30/14 End: 05/31/15 Due: 05/31/16

A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)

Phase: N/A Priority: Normal
NCT ID: NCT03528577 Org: User:
Start: 09/22/18 End: 08/03/19 Due: 08/03/20

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02737332 Org: User:
Start: 03/21/16 End: 02/27/17 Due: 02/27/18

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Phase: N/A Priority: Normal
NCT ID: NCT04314531 Org: User:
Start: 07/01/20 End: 11/30/25 Due: 11/30/26

Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04066504 Org: User:
Start: 03/11/19 End: 03/14/25 Due: 03/14/26